Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge & networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 18, 2019
BC Platforms
|
Series C | $15M | Analytics | — |
May 9, 2017
BC Platforms
|
Series B | $10M | Analytics | Yes |
Jun 27, 2005
Neovacs
|
Series Unknown | — | Biotechnology | Yes |